Therapeutic Area | MeSH |
---|---|
stomatognathic diseases | D009057 |
signs and symptoms pathological conditions | D013568 |
Tradename | Company | Number | Date | Products |
---|---|---|---|---|
RAVOCAINE AND NOVOCAIN W/ LEVOPHED | Eastman Kodak | N-008592 DISCN | 1982-01-01 | 1 products |
Tradename | Company | Number | Date | Products |
---|---|---|---|---|
RAVOCAINE AND NOVOCAIN W/ NEO-COBEFRIN | Eastman Kodak | N-008592 DISCN | 1982-01-01 | 1 products |
Brand Name | Status | Last Update |
---|---|---|
isocaine isocaine with levonordefrin | 2007-03-30 |
Indication | Ontology | MeSH | ICD-10 |
---|---|---|---|
pain | EFO_0003843 | D010146 | R52 |
toothache | — | D014098 | K08.89 |
oral ulcer | — | D019226 | — |
substance withdrawal syndrome | EFO_0005800 | D013375 | — |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Local anesthesia | D000772 | — | — | — | 1 | 1 | — | 1 | 3 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Postoperative pain | D010149 | — | G89.18 | — | — | — | — | 2 | 2 |
Pulpitis | D011671 | EFO_1001139 | K04.0 | — | — | — | — | 2 | 2 |
Pain | D010146 | EFO_0003843 | R52 | — | — | — | — | 1 | 1 |
Edema | D004487 | — | R60.9 | — | — | — | — | 1 | 1 |
Trismus | D014313 | — | — | — | — | — | — | 1 | 1 |
Diabetes mellitus | D003920 | EFO_0000400 | E08-E13 | — | — | — | — | 1 | 1 |
Acute kidney injury | D058186 | — | N17 | — | — | — | — | 1 | 1 |
End stage liver disease | D058625 | EFO_1001311 | K72.1 | — | — | — | — | 1 | 1 |
Liver failure | D017093 | — | K72.9 | — | — | — | — | 1 | 1 |
Hepatic insufficiency | D048550 | — | — | — | — | — | — | 1 | 1 |
Drug common name | Levonordefrin |
INN | corbadrine |
Description | Alpha-methylnoradrenaline is a catecholamine in which the 2-aminoethyl group is substituted with a hydroxy group at C-1 and a methyl group at C-2, with configurations 1R,2S. A metabolite of alpha-methyl-L-dopa, it is an alpha2-adrenergic agonist and acts as a topical nasal decongestant and vasoconstrictor, most often used in dentistry. It has a role as an alpha-adrenergic agonist, a vasoconstrictor agent and a nasal decongestant. |
Classification | Small molecule |
Drug class | — |
Image (chem structure or protein) | ![]() |
Structure (InChI/SMILES or Protein Sequence) | C[C@H](N)[C@H](O)c1ccc(O)c(O)c1 |
PDB | — |
CAS-ID | 829-74-3 |
RxCUI | — |
ChEMBL ID | CHEMBL677 |
ChEBI ID | 10304 |
PubChem CID | 164739 |
DrugBank | DB06707 |
UNII ID | V008L6478D (ChemIDplus, GSRS) |